|By PR Newswire||
|August 7, 2014 05:21 PM EDT||
BETHESDA, Md., Aug. 7, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) is hosting top industry suppliers and experts at the 2014 Universe of Pre-Filled Syringes and Injection Devices in Huntington Beach, California, Oct. 6-7.
This is the premier conference where industry leaders can meet with colleagues from drug and biologic manufacturing, suppliers, regulatory professionals, and academicians from around the globe, who will discuss today's challenges with drug delivery and packaging technologies, formulation development, and improving patient outcomes.
"PDA remains at the forefront of bringing together the therapy manufacturers and the best innovations in drug delivery technologies from the supplier community," says PDA President Richard Johnson. "The Universe of Pre-Filled Syringes Conference has a long track record of mentoring the exchange of information our members need to stay at the forefront of drug delivery."
Plenary sessions include expert talks from Ernst & Young, connectMeSmart, Amgen, Mylan, the U.S. FDA and the European regulators.
PDA has confirmed that FDA's Lana Shiu, MD, Director, Regulatory, Center for Device and Radiological Health will speak in the third plenary session of the meeting to discuss challenges and pitfalls for marketing applications when prefilled syringes, auto-injectors and combination products are referenced.
Nearly 100 vendors will be on hand to discuss their related products in the large exhibitor hall. The 2014 PDA Drug Delivery Combination Products Workshop follows the Universe of Pre-Filled Syringes conference. PDA also is offering four courses following the conference, including its new Prefilled Syringe User Requirements course.
For more information on the conference, the exhibition, the workshop and the courses, go to www.pda.org/prefilled2014.
About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
Media Inquiries: Walt Morris, 301-656-5900, x. 148; [email protected]
SOURCE Parenteral Drug Association
Jul. 7, 2015 02:00 AM EDT Reads: 1,232
Jul. 7, 2015 01:15 AM EDT Reads: 855
Jul. 6, 2015 11:00 PM EDT Reads: 1,921
Jul. 6, 2015 07:45 PM EDT Reads: 1,904
Jul. 6, 2015 07:45 PM EDT Reads: 1,616
Jul. 6, 2015 07:00 PM EDT Reads: 1,137
Jul. 6, 2015 06:15 PM EDT Reads: 1,967
Jul. 6, 2015 05:30 PM EDT Reads: 1,177
Jul. 6, 2015 05:00 PM EDT Reads: 1,979
Jul. 6, 2015 05:00 PM EDT Reads: 2,162
Jul. 6, 2015 04:30 PM EDT Reads: 693
Jul. 6, 2015 04:15 PM EDT Reads: 1,577
Jul. 6, 2015 03:45 PM EDT Reads: 1,767
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
Jul. 6, 2015 03:00 PM EDT Reads: 1,810
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
Jul. 6, 2015 03:00 PM EDT Reads: 3,048